Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTasci, Elif Senocak
dc.contributor.authorKutlu, Yasin
dc.contributor.authorOlmez, Omer Fatih
dc.contributor.authorMutlu, Arda Ulas
dc.contributor.authorGundogdu, Yasemin
dc.contributor.authorSeyyar, Mustafa
dc.contributor.authorSahin, Elif
dc.contributor.authorCabuk, Devrim
dc.contributor.authorMajidova, Nargiz
dc.contributor.authorUgurlu, Irem
dc.contributor.authorDemirci, Ayse
dc.contributor.authorAydin, Dincer
dc.contributor.authorCavdar, Eyup
dc.contributor.authorBayram, Selami
dc.contributor.authorYildirim, Nilgun
dc.contributor.authorKaratas, Fatih
dc.contributor.authorEryilmaz, Melek Karakurt
dc.contributor.authorCaglayan, Dilek
dc.contributor.authorMenekse, Serkan
dc.contributor.authorKut, Engin
dc.contributor.authorArak, Haci
dc.contributor.authorKeser, Murat
dc.contributor.authorSunar, Veli
dc.contributor.authorPerkin, Perihan
dc.contributor.authorSakalar, Teoman
dc.contributor.authorOyan, Basak
dc.contributor.authorSonmez, Ozlem
dc.contributor.authorOzer, Leyla
dc.contributor.authorYildiz, Ibrahim
dc.date.accessioned2025-10-16T15:13:32Z
dc.date.issued2024
dc.identifier.doi10.1080/14656566.2024.2337261
dc.identifier.otherWOS:001196635300001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5855
dc.publisherTAYLOR \& FRANCIS LTD
dc.sourceEXPERT OPINION ON PHARMACOTHERAPY
dc.subjectCapecitabine
dc.subjectbreast cancer
dc.subjectresidual tumor
dc.subjecttriple negative
dc.subjecttoxicity
dc.titleEfficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS